Report Detail

Pharma & Healthcare Global and Plasma Derived Medicine Market Insights, Forecast to 2026

  • RnM4207839
  • |
  • 15 September, 2020
  • |
  • Global
  • |
  • 142 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Plasma Derived Medicine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Plasma Derived Medicine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market
    • 1.4.1 Global Plasma Derived Medicine Market Size Growth Rate
    • 1.4.2 Albumin
    • 1.4.3 Coagulation Factor
    • 1.4.4 Immunoglobulin
    • 1.4.5 Others
  • 1.5 Market 5
    • 1.5.1 Global Plasma Derived Medicine Market Size Growth Rate 5
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Plasma Derived Medicine Market Size, Estimates and Forecasts
    • 2.1.1 Global Plasma Derived Medicine Revenue 2015-2026
    • 2.1.2 Global Plasma Derived Medicine Sales 2015-2026
  • 2.2 Global Plasma Derived Medicine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Plasma Derived Medicine Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Plasma Derived Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Plasma Derived Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Plasma Derived Medicine Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Plasma Derived Medicine Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Plasma Derived Medicine Revenue Forecast by Region (2021-2026)

3 Global Plasma Derived Medicine Competitor Landscape by Players

  • 3.1 Global Top Plasma Derived Medicine Sales by Manufacturers
    • 3.1.1 Global Plasma Derived Medicine Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Plasma Derived Medicine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Plasma Derived Medicine Manufacturers by Revenue
    • 3.2.1 Global Plasma Derived Medicine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Plasma Derived Medicine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Plasma Derived Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Plasma Derived Medicine Revenue in 2019
    • 3.2.5 Global Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Plasma Derived Medicine Price by Manufacturers
  • 3.4 Global Plasma Derived Medicine Manufacturing Base Distribution, Product Types
    • 3.4.1 Plasma Derived Medicine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Plasma Derived Medicine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Plasma Derived Medicine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size (2015-2026)

  • 4.1 Global Plasma Derived Medicine Market Size (2015-2020)
    • 4.1.1 Global Plasma Derived Medicine Sales (2015-2020)
    • 4.1.2 Global Plasma Derived Medicine Revenue (2015-2020)
    • 4.1.3 Plasma Derived Medicine Average Selling Price (ASP) (2015-2026)
  • 4.2 Global Plasma Derived Medicine Market Size Forecast (2021-2026)
    • 4.2.1 Global Plasma Derived Medicine Sales Forecast (2021-2026)
    • 4.2.2 Global Plasma Derived Medicine Revenue Forecast (2021-2026)
    • 4.2.3 Plasma Derived Medicine Average Selling Price (ASP) Forecast (2021-2026)
  • 4.3 Global Plasma Derived Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size 5 (2015-2026)

  • 5.1 Global Plasma Derived Medicine Market Size 5 (2015-2020)
    • 5.1.1 Global Plasma Derived Medicine Sales 5 (2015-2020)
    • 5.1.2 Global Plasma Derived Medicine Revenue 5 (2015-2020)
    • 5.1.3 Plasma Derived Medicine Price 5 (2015-2020)
  • 5.2 Plasma Derived Medicine Market Size Forecast 5 (2021-2026)
    • 5.2.1 Global Plasma Derived Medicine Sales Forecast 5 (2021-2026)
    • 5.2.2 Global Plasma Derived Medicine Revenue Forecast 5 (2021-2026)
    • 5.2.3 Global Plasma Derived Medicine Price Forecast 5 (2021-2026)

6 by Players, and

  • 6.1 Plasma Derived Medicine Market Size YoY Growth 2015-2026
    • 6.1.1 Plasma Derived Medicine Sales YoY Growth 2015-2026
    • 6.1.2 Plasma Derived Medicine Revenue YoY Growth 2015-2026
    • 6.1.3 Plasma Derived Medicine Market Share in Global Market 2015-2026
  • 6.2 Plasma Derived Medicine Market Size by Players (International and Local Players)
    • 6.2.1 Top Plasma Derived Medicine Players by Sales (2015-2020)
    • 6.2.2 Top Plasma Derived Medicine Players by Revenue (2015-2020)
  • 6.3 Plasma Derived Medicine Historic Market Review (2015-2020)
    • 6.3.1 Plasma Derived Medicine Sales Market Share (2015-2020)
    • 6.3.2 Plasma Derived Medicine Revenue Market Share (2015-2020)
    • 6.3.3 Plasma Derived Medicine Price (2015-2020)
  • 6.4 Plasma Derived Medicine Market Estimates and Forecasts (2021-2026)
    • 6.4.1 Plasma Derived Medicine Sales Forecast (2021-2026)
    • 6.4.2 Plasma Derived Medicine Revenue Forecast (2021-2026)
    • 6.4.3 Plasma Derived Medicine Price Forecast (2021-2026)
  • 6.5 Plasma Derived Medicine Historic Market Review 5 (2015-2020)
    • 6.5.1 Plasma Derived Medicine Sales Market Share 5 (2015-2020)
    • 6.5.2 Plasma Derived Medicine Revenue Market Share 5 (2015-2020)
    • 6.5.3 Plasma Derived Medicine Price 5 (2015-2020)
  • 6.6 Plasma Derived Medicine Market Estimates and Forecasts 5 (2021-2026)
    • 6.6.1 Plasma Derived Medicine Sales Forecast 5 (2021-2026)
    • 6.6.2 Plasma Derived Medicine Revenue Forecast 5 (2021-2026)
    • 6.6.3 Plasma Derived Medicine Price Forecast 5 (2021-2026)

7 North America

  • 7.1 North America Plasma Derived Medicine Market Size YoY Growth 2015-2026
  • 7.2 North America Plasma Derived Medicine Market Facts & Figures by Country
    • 7.2.1 North America Plasma Derived Medicine Sales by Country (2015-2020)
    • 7.2.2 North America Plasma Derived Medicine Revenue by Country (2015-2020)
    • 7.2.3 United States
    • 7.2.4 Canada
    • 7.2.5 Mexico

8 Europe

  • 8.1 Europe Plasma Derived Medicine Market Size YoY Growth 2015-2026
  • 8.2 Europe Plasma Derived Medicine Market Facts & Figures by Country
    • 8.2.1 Europe Plasma Derived Medicine Sales by Country
    • 8.2.2 Europe Plasma Derived Medicine Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 UK
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Plasma Derived Medicine Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Plasma Derived Medicine Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Plasma Derived Medicine Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Plasma Derived Medicine Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Indonesia
    • 9.2.9 Thailand
    • 9.2.10 Malaysia
    • 9.2.11 Philippines
    • 9.2.12 Vietnam

10 Latin America

  • 10.1 Latin America Plasma Derived Medicine Market Size YoY Growth 2015-2026
  • 10.2 Latin America Plasma Derived Medicine Market Facts & Figures by Country
    • 10.2.1 Latin America Plasma Derived Medicine Sales by Country
    • 10.2.2 Latin America Plasma Derived Medicine Revenue by Country
    • 10.2.3 Brazil

11 Middle East and Africa

  • 11.1 Middle East and Africa Plasma Derived Medicine Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Plasma Derived Medicine Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Plasma Derived Medicine Sales by Country
    • 11.2.2 Middle East and Africa Plasma Derived Medicine Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 GCC Countries
    • 11.2.5 Egypt
    • 11.2.6 South Africa

12 Company Profiles

  • 12.1 Grifols
    • 12.1.1 Grifols Corporation Information
    • 12.1.2 Grifols Description and Business Overview
    • 12.1.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Grifols Plasma Derived Medicine Products Offered
    • 12.1.5 Grifols Recent Development
  • 12.2 SK Plasma
    • 12.2.1 SK Plasma Corporation Information
    • 12.2.2 SK Plasma Description and Business Overview
    • 12.2.3 SK Plasma Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 SK Plasma Plasma Derived Medicine Products Offered
    • 12.2.5 SK Plasma Recent Development
  • 12.3 Fusion Health Care
    • 12.3.1 Fusion Health Care Corporation Information
    • 12.3.2 Fusion Health Care Description and Business Overview
    • 12.3.3 Fusion Health Care Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Fusion Health Care Plasma Derived Medicine Products Offered
    • 12.3.5 Fusion Health Care Recent Development
  • 12.4 Biotest AG
    • 12.4.1 Biotest AG Corporation Information
    • 12.4.2 Biotest AG Description and Business Overview
    • 12.4.3 Biotest AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Biotest AG Plasma Derived Medicine Products Offered
    • 12.4.5 Biotest AG Recent Development
  • 12.5 GC Pharma
    • 12.5.1 GC Pharma Corporation Information
    • 12.5.2 GC Pharma Description and Business Overview
    • 12.5.3 GC Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 GC Pharma Plasma Derived Medicine Products Offered
    • 12.5.5 GC Pharma Recent Development
  • 12.6 Baxter International
    • 12.6.1 Baxter International Corporation Information
    • 12.6.2 Baxter International Description and Business Overview
    • 12.6.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Baxter International Plasma Derived Medicine Products Offered
    • 12.6.5 Baxter International Recent Development
  • 12.7 LFB
    • 12.7.1 LFB Corporation Information
    • 12.7.2 LFB Description and Business Overview
    • 12.7.3 LFB Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 LFB Plasma Derived Medicine Products Offered
    • 12.7.5 LFB Recent Development
  • 12.8 Octapharma AG
    • 12.8.1 Octapharma AG Corporation Information
    • 12.8.2 Octapharma AG Description and Business Overview
    • 12.8.3 Octapharma AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Octapharma AG Plasma Derived Medicine Products Offered
    • 12.8.5 Octapharma AG Recent Development
  • 12.9 CSL Limited
    • 12.9.1 CSL Limited Corporation Information
    • 12.9.2 CSL Limited Description and Business Overview
    • 12.9.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 CSL Limited Plasma Derived Medicine Products Offered
    • 12.9.5 CSL Limited Recent Development
  • 12.10 BPL
    • 12.10.1 BPL Corporation Information
    • 12.10.2 BPL Description and Business Overview
    • 12.10.3 BPL Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 BPL Plasma Derived Medicine Products Offered
    • 12.10.5 BPL Recent Development
  • 12.11 Grifols
    • 12.11.1 Grifols Corporation Information
    • 12.11.2 Grifols Description and Business Overview
    • 12.11.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Grifols Plasma Derived Medicine Products Offered
    • 12.11.5 Grifols Recent Development
  • 12.12 Kedrion Biopharma
    • 12.12.1 Kedrion Biopharma Corporation Information
    • 12.12.2 Kedrion Biopharma Description and Business Overview
    • 12.12.3 Kedrion Biopharma Sales, Revenue and Gross Margin (2015-2020)
    • 12.12.4 Kedrion Biopharma Products Offered
    • 12.12.5 Kedrion Biopharma Recent Development
  • 12.13 RAAS
    • 12.13.1 RAAS Corporation Information
    • 12.13.2 RAAS Description and Business Overview
    • 12.13.3 RAAS Sales, Revenue and Gross Margin (2015-2020)
    • 12.13.4 RAAS Products Offered
    • 12.13.5 RAAS Recent Development
  • 12.14 Tiantan Bio
    • 12.14.1 Tiantan Bio Corporation Information
    • 12.14.2 Tiantan Bio Description and Business Overview
    • 12.14.3 Tiantan Bio Sales, Revenue and Gross Margin (2015-2020)
    • 12.14.4 Tiantan Bio Products Offered
    • 12.14.5 Tiantan Bio Recent Development
  • 12.15 Hualan Biological Engineering
    • 12.15.1 Hualan Biological Engineering Corporation Information
    • 12.15.2 Hualan Biological Engineering Description and Business Overview
    • 12.15.3 Hualan Biological Engineering Sales, Revenue and Gross Margin (2015-2020)
    • 12.15.4 Hualan Biological Engineering Products Offered
    • 12.15.5 Hualan Biological Engineering Recent Development
  • 12.16 BOYA Bio-Pharmaceutical
    • 12.16.1 BOYA Bio-Pharmaceutical Corporation Information
    • 12.16.2 BOYA Bio-Pharmaceutical Description and Business Overview
    • 12.16.3 BOYA Bio-Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 12.16.4 BOYA Bio-Pharmaceutical Products Offered
    • 12.16.5 BOYA Bio-Pharmaceutical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Plasma Derived Medicine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Plasma Derived Medicine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Plasma Derived Medicine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Derived Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment , the Plasma Derived Medicine market is segmented into
    Albumin
    Coagulation Factor
    Immunoglobulin
    Others

    Segment 5, the Plasma Derived Medicine market is segmented into
    Hospitals
    Clinics
    Other

    Regional and Country-level Analysis
    The Plasma Derived Medicine market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Plasma Derived Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, United States, Canada, Germany, France, UK, Italy, Russia, China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Brazil, Turkey, GCC Countries, Egypt, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast , and 5 segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Plasma Derived Medicine Market Share Analysis
    Plasma Derived Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Plasma Derived Medicine business, the date to enter into the Plasma Derived Medicine market, Plasma Derived Medicine product introduction, recent developments, etc.
    The major vendors covered:
    Grifols
    SK Plasma
    Fusion Health Care
    Biotest AG
    GC Pharma
    Baxter International
    LFB
    Octapharma AG
    CSL Limited
    BPL
    China Biologic Products
    Kedrion Biopharma
    RAAS
    Tiantan Bio
    Hualan Biological Engineering
    BOYA Bio-Pharmaceutical


    Summary:
    Get latest Market Research Reports on Plasma Derived Medicine. Industry analysis & Market Report on Plasma Derived Medicine is a syndicated market report, published as Global and Plasma Derived Medicine Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Plasma Derived Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,048.88
    4,573.33
    6,097.77
    3,324.31
    4,986.46
    6,648.62
    408,201.30
    612,301.95
    816,402.60
    286,600.47
    429,900.71
    573,200.94
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report